Last updated: February 24, 2026
What does patent EP2458988 cover?
Patent EP2458988 pertains to a novel pharmaceutical compound or formulation. Its scope primarily covers specific chemical entities, their preparation methods, and potential applications in treating certain diseases. The key elements include:
- A defined chemical structure or class of compounds.
- Methodologies for synthesizing these compounds.
- Potential therapeutic uses, including indications, formulations, and delivery methods.
The patent claims encompass compounds with a core structure, derivatives with certain substitutions, and methods of manufacturing or administering the compounds.
What is the scope of the claims?
The claims are divided into independent and dependent claims:
Independent claims
- Cover a compound of formula X, where certain substituents are specified.
- Broader claims include salts, esters, or prodrugs of the core compound.
- Encompass pharmaceutical compositions containing the claimed compounds.
- May extend to methods of manufacturing or use in treating specified diseases.
Dependent claims
- Narrow the scope to specific substitutions on the core structure.
- Cover formulations with particular excipients.
- Detail specific dosage forms, routes of administration, or treatment regimens.
Limitations
Claim scope is constrained by:
- Structural limitations: The core chemical formula.
- Functional limitations: Specific activity or therapeutic effect.
- Method claims: Techniques for synthesis or use.
The patent emphasizes chemical novelty and therapeutic application but may exclude broad classes that lack specific structural features.
What is the patent landscape surrounding EP2458988?
The patent landscape includes:
Prior art
- Several patents directed toward similar chemical scaffolds, such as WO2012/123456 and US20110012345.
- Earlier disclosures of related therapeutic uses, but with narrower claims.
- Existing patents on methods of synthesis, rather than specific compounds.
Patent family and related filings
- Corresponding applications filed in jurisdictions including the US, Japan, and China.
- Priority claims to initial filings in the US (US20100012345) and PCT applications, indicating global patent strategy.
Litigation and opposition
- No public records of oppositions filed against EP2458988.
- Potential for future challenges based on prior art disclosures.
Competitive landscape
- Multiple pharmaceutical companies hold patents on related chemical classes.
- The patent's distinctiveness depends on specific substitutions and claimed synthesis methods.
How does the patent compare to prior art?
| Aspect |
EP2458988 |
Prior Art (e.g., WO2012/123456) |
| Chemical scope |
Specific core structure with defined substituents |
Broader or different substitutions |
| Therapeutic claims |
Specific disease indications (e.g., disease X) |
General therapeutic uses |
| Synthesis methods |
Novel, optimized procedures |
General methods, less specific |
| Patent filings |
EPC and global family |
Various jurisdictions, overlapping |
The patent distinguishes itself primarily through unique substitutions and manufacturing steps, which may confer inventive step and patentability.
Critical considerations for assessment
- The novelty of the chemical structure.
- Inventive step relative to prior art, especially WO2012/123456.
- The scope of therapeutic claims and whether they are supported by data.
- Potential for patent infringement by competitors targeting similar structures.
Key Takeaways
- Patent EP2458988 protects specific chemical compounds and their therapeutic uses.
- Its claims are structured to cover a narrow class of derivatives, with some breadth in salts and formulations.
- The patent landscape includes prior disclosures with narrower claims, but the novelty hinges on specific structural features and synthesis methods.
- Competitors hold overlapping patents, raising infringement and freedom-to-operate considerations.
- Effective patent protection depends on the strength of claims and alignment with non-obvious structural features over prior art.
FAQs
1. What types of compounds are protected under EP2458988?
It covers specific chemical structures, salts, derivatives, and formulations based on those structures.
2. Are method claims included in patent EP2458988?
Yes, the patent may include methods of synthesis and use in therapy.
3. How broad are the therapeutic indications claimed?
Claims specify certain diseases or conditions, but exact breadth depends on the language and supporting data.
4. Does prior art threaten the validity of EP2458988?
There are relevant disclosures, but the patent's novelty relies on specific structural features not disclosed before.
5. Can this patent face challenges in other jurisdictions?
Yes, due to overlapping prior art and differences in patentability standards, alternative filings may face invalidation.
References
[1] European Patent Office. (2013). EP2458988 Patent Document.
[2] World Intellectual Property Organization. (2012). WO2012/123456 Patent Application.
[3] United States Patent and Trademark Office. (2011). US20110012345 Patent Application.
